Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- NIH Updated Policy Guidance for Subaward/Consortium Written Agreements
(NOT-OD-23-133)
National Institutes of Health
General Notices
- Notice of NIDCR Participation in PAR-23-156 Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
(NOT-DE-23-011)
National Institute of Dental and Craniofacial Research
- Notice of Participation of the NICHD in NOT-MD-23-002, "Notice of Special Interest (NOSI): Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations"
(NOT-HD-23-010)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Participation of the NICHD in NOT-MD-23-003, "Notice of Special Interest (NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective Interventions"
(NOT-HD-23-011)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NHLBI TOPMed Announces Fellowship Program to Promote Diversity, Equity, and Inclusion in the Genomic Data Science Research Workforce
(NOT-HL-23-086)
National Heart, Lung, and Blood Institute
- NINDS Announces Plans to Publish the NINDS Rigor Champions Prize Challenge Competition
(NOT-NS-23-085)
National Institute of Neurological Disorders and Stroke
- Notice of Information: Anticipated Publication of the PHS 2023-2 Omnibus Solicitations of the NIH, CDC and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications
(NOT-OD-23-124)
Office of the Director, NIH
- Notice Regarding the Data Management and Sharing Plan for Applications Submitted to PAR-22-248: HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program and PAR-22-252: Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models
(NOT-OD-23-131)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Notice of Changes to Funding Opportunities
- Notice of Participation of the NIAAA in PAR-23-191 "HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)"
(NOT-AA-23-013)
National Institute on Alcohol Abuse and Alcoholism
- Notice of Change to RFA-AG-24-009, "Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)"
(NOT-AG-23-028)
National Institute on Aging
- Notice to Extend the Expiration Date for RFA-DC-20-002 NIDCD's Mentored Research Pathway for Otolaryngology Residents and Medical Students (R25 - Clinical Trial Not Allowed)
(NOT-DC-23-011)
National Institute on Deafness and Other Communication Disorders
- Notice of NEI Participation in RFA-OD-23-050, "Emergency Award: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed)"
(NOT-EY-23-006)
National Eye Institute
- Notice of NEI Participation in RFA-OD-23-051, "Emergency Award: RADx-UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)"
(NOT-EY-23-007)
National Eye Institute
- Notice of Correction to Due Date for Letter of Intent for RFA-MH-23-265 "Developing Measures to Advance Quality in Mental Health Care Services (R01 Clinical Trial Not Allowed)"
(NOT-MH-23-320)
National Institute of Mental Health
- Notice of the Extension of the Expiration Date for NOT-OD-23-040: Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21)
(NOT-OD-23-130)
Office of the Director, NIH
Notices of Special Interest
- Notice of Special Interest (NOSI): Small Research Grants for Innovations in Healthy Longevity Research
(NOT-AG-23-027)
National Institute on Aging
- Notice of Special Interest (NOSI): Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults
(NOT-MH-23-250)
National Institute of Mental Health
Funding Opportunities
- Emergency Medicine Research Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent Clinical Trial Allowed)
(PAR-23-151)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
National Institute on Drug Abuse
- NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
(PAR-23-183)
National Library of Medicine
- Alcohol Health Services Research (R01 Clinical Trial Optional)
(PAR-23-185)
National Institute on Alcohol Abuse and Alcoholism
- Alcohol Health Services Research (R34 Clinical Trial Optional)
(PAR-23-186)
National Institute on Alcohol Abuse and Alcoholism
- Alcohol Treatment and Recovery Research (R01 Clinical Trial Required)
(PAR-23-187)
National Institute on Alcohol Abuse and Alcoholism
- Alcohol Treatment and Recovery Research (R34 Clinical Trial required)
(PAR-23-188)
National Institute on Alcohol Abuse and Alcoholism
- Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
(PAR-23-193)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): October 3, 2023, April 3, 2024, October 3, 2024, April 3, 2025, - Understanding Gene-Environment Interactions in Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)
(RFA-AG-24-021)
National Institute on Aging
- Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed)
(RFA-AG-24-022)
National Institute on Aging
- Preclinical Studies to Characterize the Impact of Toxicants on Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)
(RFA-AG-24-023)
National Institute on Aging
- Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)?
(RFA-AG-24-036)
National Institute on Aging
- Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)?
(RFA-AG-24-038)
National Institute on Aging
- Analyzing Early Events in TB and TB/HIV Infection for Interventional Targets (R01 Clinical Trial Not Allowed)
(RFA-AI-23-029)
National Institute of Allergy and Infectious Diseases
- Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed)
(RFA-AI-23-032)
National Institute of Allergy and Infectious Diseases
- Patient Engagement Resource Centers to Inform SUD Treatment Services Research (R24 Clinical Trial Optional)
(RFA-DA-24-016)
National Institute on Drug Abuse
- Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required)
(RFA-DA-24-024)
National Institute on Drug Abuse
- Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed)
(RFA-DA-24-028)
National Institute on Drug Abuse
- Advancing Psychedelics Research for Treating Addiction (R61/R33 Basic Experimental Study with Humans Required)
(RFA-DA-24-029)
National Institute on Drug Abuse
- Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Biostatistics Research Center (U01 Clinical Trial Not Allowed)
(RFA-DK-23-009)
National Institute of Diabetes and Digestive and Kidney Diseases
- Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Clinical Centers (U01 Clinical Trial Not Allowed)
(RFA-DK-23-010)
National Institute of Diabetes and Digestive and Kidney Diseases
- Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDUL) (P50 Clinical Trial Not Allowed)
(RFA-HD-24-005)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
- Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional)
(RFA-NS-23-027)
National Institute of Neurological Disorders and Stroke
- Assessment of TBI-related ADRD Pathology Related to Cognitive Impairment and Dementia Outcomes (U01 - Clinical Trial Not Allowed)
(RFA-NS-24-003)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
- Early-Stage Therapy Development for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed)
(RFA-NS-24-010)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail)(link sends e-mail) or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail)(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail)(link sends e-mail).